LncRNA HOTTIP inhibits cell pyroptosis by targeting miR-148a-3p/AKT2 axis in ovarian cancer

被引:67
作者
Tan, Cai [1 ]
Liu, Wei [2 ]
Zheng, Zhi-Hua [3 ]
Wan, Xiao-Gang [3 ]
机构
[1] Jiangxi Maternal & Child Hlth Hosp, Dept Hlth, 318 Bayi Rd, Nanchang 330006, Jiangxi, Peoples R China
[2] Jiangxi Maternal & Child Hlth Hosp, Dept Reprod Hlth, Nanchang, Jiangxi, Peoples R China
[3] Nanchang Univ, Affiliated Hosp 2, Dept Gen Surg, Nanchang, Jiangxi, Peoples R China
关键词
AKT2; HOTTIP; miR‐ 148a‐ 3p; ovarian cancer; pyroptosis; LONG NONCODING RNA; INDUCED APOPTOSIS; ACTIVATION; AKT2; PROGRESSION; PATHWAYS; GROWTH; DEATH; ASK1; INFLAMMASOMES;
D O I
10.1002/cbin.11588
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Long noncoding RNA HOTTIP is a crucial regulator in multiple types of cancer, including ovarian cancer (OC). However, the biological roles and underlying mechanisms of HOTTIP in OC have rarely been studied. Hence, this study aimed to investigate the functional correlation between HOTTIP and pyroptosis in OC progression. The expression of HOTTIP in OC tissues and cell lines was characterized by quantitative real-time PCR. Cell proliferation was evaluated using Cell Counting Kit-8 and clone formation assays. Western blot was performed to quantify protein levels. A dual-luciferase reporter assay was used to analyze the molecular interaction among HOTTIP, miR-148a-3p, and AKT2. The expression of HOTTIP was significantly upregulated in OC tissue samples and cell lines. The silencing of HOTTIP led to the inhibition of cell proliferation and NLRP1 inflammasome-mediated pyroptosis. In addition, HOTTIP increased AKT2 expression by negatively regulating miR-148a-3p and then inhibited ASK1/JNK signaling. Further rescue experiments revealed that downregulation of miR-148a-3p and overexpression of AKT2 obviously diminished the effects of HOTTIP downregulation in OC cells. Thus, our study elucidated a novel pyroptosis-related mechanism by which HOTTIP participated in OC progression, which might provide a theoretical reference for clinical treatment.
引用
收藏
页码:1487 / 1497
页数:11
相关论文
共 40 条
[1]   Long Noncoding RNA and Cancer: A New Paradigm [J].
Bhan, Arunoday ;
Soleimani, Milad ;
Mandal, Subhrangsu S. .
CANCER RESEARCH, 2017, 77 (15) :3965-3981
[2]   RETRACTED: miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2 (Retracted article. See vol. 49, pg. 17, 2023) [J].
Cao, Huiyan ;
Liu, Zhiming ;
Wang, Rong ;
Zhang, Xiaodong ;
Yi, Wenfa ;
Nie, Guanyuan ;
Yu, Yong ;
Wang, Guolu ;
Zhu, Mingting .
ONCOLOGY REPORTS, 2017, 37 (01) :147-154
[3]   The NLRP1 inflammasomes [J].
Chavarria-Smith, Joseph ;
Vance, Russell E. .
IMMUNOLOGICAL REVIEWS, 2015, 265 (01) :22-34
[4]   The MC4 receptor agonist RO27-3225 inhibits NLRP1-dependent neuronal pyroptosis via the ASK1/JNK/p38 MAPK pathway in a mouse model of intracerebral haemorrhage [J].
Chen, Shengpan ;
Zuo, Yuchun ;
Huang, Lei ;
Sherchan, Prativa ;
Zhang, Jian ;
Yu, Zhengtao ;
Peng, Jianhua ;
Zhang, Junyi ;
Zhao, Lianhua ;
Doycheva, Desislava ;
Liu, Fei ;
Zhang, John H. ;
Xia, Ying ;
Tang, Jiping .
BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (09) :1341-1356
[5]   Pyroptosis: A new frontier in cancer [J].
Fang, Yuan ;
Tian, Shengwang ;
Pan, Yutian ;
Li, Wei ;
Wang, Qiming ;
Tang, Yu ;
Yu, Tao ;
Wu, Xi ;
Shi, Yongkang ;
Ma, Pei ;
Shu, Yongqian .
BIOMEDICINE & PHARMACOTHERAPY, 2020, 121
[6]   Ovarian cancer: screening and future directions [J].
Gupta, Keshav Kumar ;
Gupta, Vinay Kumar ;
Naumann, Robert Wendel .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (01) :195-200
[7]   NLRP3 inflammasome: Its regulation and involvement in atherosclerosis [J].
Hoseini, Zahra ;
Sepahvand, Fatemeh ;
Rashidi, Bahman ;
Sahebkar, Amirhossein ;
Masoudifar, Aria ;
Mirzaei, Hamed .
JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (03) :2116-2132
[8]   The emerging role of IncRNAs in cancer [J].
Huarte, Maite .
NATURE MEDICINE, 2015, 21 (11) :1253-1261
[9]   Ovarian cancer [J].
Jayson, Gordon C. ;
Kohn, Elise C. ;
Kitchener, Henry C. ;
Ledermann, Jonathan A. .
LANCET, 2014, 384 (9951) :1376-1388
[10]  
Jiang MC, 2019, AM J CANCER RES, V9, P1354